Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C78H111N21O19 |
Molecular Weight | 1646.8452 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 12 / 12 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(C)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC2=CNC=N2)C(=O)N[C@H](CC3=CC=CC=C3)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC4=CNC5=CC=CC=C45)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N6CCC[C@H]6C(=O)N[C@@H](C(C)C)C(N)=O
InChI
InChIKey=UAHFGYDRQSXQEB-LEBBXHLNSA-N
InChI=1S/C78H111N21O19/c1-5-6-19-52(91-75(116)61(41-101)97-72(113)57(34-46-24-26-49(103)27-25-46)94-74(115)60(40-100)88-44(4)102)68(109)92-54(28-29-64(105)106)70(111)96-59(36-48-38-83-42-87-48)73(114)93-56(33-45-16-8-7-9-17-45)71(112)90-53(22-14-31-84-78(81)82)69(110)95-58(35-47-37-85-51-20-11-10-18-50(47)51)67(108)86-39-63(104)89-55(21-12-13-30-79)77(118)99-32-15-23-62(99)76(117)98-65(43(2)3)66(80)107/h7-11,16-18,20,24-27,37-38,42-43,52-62,65,85,100-101,103H,5-6,12-15,19,21-23,28-36,39-41,79H2,1-4H3,(H2,80,107)(H,83,87)(H,86,108)(H,88,102)(H,89,104)(H,90,112)(H,91,116)(H,92,109)(H,93,114)(H,94,115)(H,95,110)(H,96,111)(H,97,113)(H,98,117)(H,105,106)(H4,81,82,84)/t52-,53-,54-,55-,56+,57-,58-,59-,60-,61-,62-,65-/m0/s1
Molecular Formula | C78H111N21O19 |
Molecular Weight | 1646.8452 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 12 / 12 |
E/Z Centers | 6 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:49:20 UTC 2023
by
admin
on
Fri Dec 15 15:49:20 UTC 2023
|
Record UNII |
QW68W3J66U
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C548
Created by
admin on Fri Dec 15 15:49:20 UTC 2023 , Edited by admin on Fri Dec 15 15:49:20 UTC 2023
|
||
|
FDA ORPHAN DRUG |
430014
Created by
admin on Fri Dec 15 15:49:20 UTC 2023 , Edited by admin on Fri Dec 15 15:49:20 UTC 2023
|
||
|
FDA ORPHAN DRUG |
292009
Created by
admin on Fri Dec 15 15:49:20 UTC 2023 , Edited by admin on Fri Dec 15 15:49:20 UTC 2023
|
||
|
EU-Orphan Drug |
EU/3/09/648
Created by
admin on Fri Dec 15 15:49:20 UTC 2023 , Edited by admin on Fri Dec 15 15:49:20 UTC 2023
|
||
|
FDA ORPHAN DRUG |
263208
Created by
admin on Fri Dec 15 15:49:20 UTC 2023 , Edited by admin on Fri Dec 15 15:49:20 UTC 2023
|
||
|
WIKIPEDIA |
Designer-drugs-AFAMELANOTIDE
Created by
admin on Fri Dec 15 15:49:20 UTC 2023 , Edited by admin on Fri Dec 15 15:49:20 UTC 2023
|
||
|
WHO-ATC |
D02BB02
Created by
admin on Fri Dec 15 15:49:20 UTC 2023 , Edited by admin on Fri Dec 15 15:49:20 UTC 2023
|
||
|
FDA ORPHAN DRUG |
502815
Created by
admin on Fri Dec 15 15:49:20 UTC 2023 , Edited by admin on Fri Dec 15 15:49:20 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
SCENESSE (AUTHORIZED: PROTOPORPHYRIA, ERYTHROPOIETIC)
Created by
admin on Fri Dec 15 15:49:20 UTC 2023 , Edited by admin on Fri Dec 15 15:49:20 UTC 2023
|
||
|
WHO-VATC |
QD02BB02
Created by
admin on Fri Dec 15 15:49:20 UTC 2023 , Edited by admin on Fri Dec 15 15:49:20 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
AFAMELANOTIDE
Created by
admin on Fri Dec 15 15:49:20 UTC 2023 , Edited by admin on Fri Dec 15 15:49:20 UTC 2023
|
PRIMARY | |||
|
DB04931
Created by
admin on Fri Dec 15 15:49:20 UTC 2023 , Edited by admin on Fri Dec 15 15:49:20 UTC 2023
|
PRIMARY | |||
|
C534526
Created by
admin on Fri Dec 15 15:49:20 UTC 2023 , Edited by admin on Fri Dec 15 15:49:20 UTC 2023
|
PRIMARY | |||
|
136034
Created by
admin on Fri Dec 15 15:49:20 UTC 2023 , Edited by admin on Fri Dec 15 15:49:20 UTC 2023
|
PRIMARY | |||
|
75921-69-6
Created by
admin on Fri Dec 15 15:49:20 UTC 2023 , Edited by admin on Fri Dec 15 15:49:20 UTC 2023
|
PRIMARY | |||
|
QW68W3J66U
Created by
admin on Fri Dec 15 15:49:20 UTC 2023 , Edited by admin on Fri Dec 15 15:49:20 UTC 2023
|
PRIMARY | |||
|
EF-157
Created by
admin on Fri Dec 15 15:49:20 UTC 2023 , Edited by admin on Fri Dec 15 15:49:20 UTC 2023
|
PRIMARY | |||
|
m1438
Created by
admin on Fri Dec 15 15:49:20 UTC 2023 , Edited by admin on Fri Dec 15 15:49:20 UTC 2023
|
PRIMARY | Merck Index | ||
|
CHEMBL2108301
Created by
admin on Fri Dec 15 15:49:20 UTC 2023 , Edited by admin on Fri Dec 15 15:49:20 UTC 2023
|
PRIMARY | |||
|
2262250
Created by
admin on Fri Dec 15 15:49:20 UTC 2023 , Edited by admin on Fri Dec 15 15:49:20 UTC 2023
|
PRIMARY | |||
|
C82655
Created by
admin on Fri Dec 15 15:49:20 UTC 2023 , Edited by admin on Fri Dec 15 15:49:20 UTC 2023
|
PRIMARY | |||
|
16154396
Created by
admin on Fri Dec 15 15:49:20 UTC 2023 , Edited by admin on Fri Dec 15 15:49:20 UTC 2023
|
PRIMARY | |||
|
SUB33758
Created by
admin on Fri Dec 15 15:49:20 UTC 2023 , Edited by admin on Fri Dec 15 15:49:20 UTC 2023
|
PRIMARY | |||
|
QW68W3J66U
Created by
admin on Fri Dec 15 15:49:20 UTC 2023 , Edited by admin on Fri Dec 15 15:49:20 UTC 2023
|
PRIMARY | |||
|
9010
Created by
admin on Fri Dec 15 15:49:20 UTC 2023 , Edited by admin on Fri Dec 15 15:49:20 UTC 2023
|
PRIMARY | |||
|
100000127697
Created by
admin on Fri Dec 15 15:49:20 UTC 2023 , Edited by admin on Fri Dec 15 15:49:20 UTC 2023
|
PRIMARY | |||
|
4836
Created by
admin on Fri Dec 15 15:49:20 UTC 2023 , Edited by admin on Fri Dec 15 15:49:20 UTC 2023
|
PRIMARY | |||
|
DTXSID40226843
Created by
admin on Fri Dec 15 15:49:20 UTC 2023 , Edited by admin on Fri Dec 15 15:49:20 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR |
Binding Assay
|
||
|
TARGET -> AGONIST |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
TARGET -> INHIBITOR |
Binding assay
Kd
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Tmax | PHARMACOKINETIC |
|
SUBCUTANEOUS ADMINISTRATION |
|
||
Biological Half-life | PHARMACOKINETIC |
|
SINGLE DOSE |
|
||